Cover Image


Coagulation Self-testing to 2020

出版商 Greystone Research Associates 商品編碼 201015
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
自我血液凝固檢驗市場:至2020年的預測 Coagulation Self-testing to 2020
出版日期: 2015年06月25日 內容資訊: 英文





  • 抗凝固劑的經濟學
    • 口服抗凝固劑
    • 凝血酵素原時間的監測
    • 競爭的血液凝固檢驗
    • 患者適合性的重要因素
    • 推動市場的要素
    • 產業的整備與競爭環境


  • PT/INR檢驗的標準化
    • 準確度
    • 取樣調查方法
    • 試驗指標檢測
    • 患者/用戶界面
    • 無線技術


  • 管理式護理與償付
    • 第三者患者訓練與支援
    • 特殊技術


  • 適應和市場區隔
    • 新的口服抗凝固劑
    • 患者人口統計
    • 法律規章和標準
    • 患者/消費者心理


  • 市售產品
  • 開發階段的產品


  • 北美
  • 西歐
  • 東歐
  • 亞洲
  • 中東、北非
  • 南美



Product Code: CST333F

The size and future potential of the coagulation self-testing market has been evolving over the past 24 months as two competing forces work to inject uncertainty into future demand. Demographic and incidence data indicate a definite upward trend in the clinical and managed care demand for anticoagulation therapeutics. But the commercialization of novel oral anticoagulants (NOACs) -a new class of drugs that does not require routine coagulation monitoring - will work to reduce demand for coagulation self-testing. The result will be a muddled global market where demand among countries and regions will vary based on individual market factors. To minimize risk and fully engage addressable markets, participants must commit to a comprehensive understanding of the key markets in which they currently, or plan to, compete.

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-testing and management. In this environment, healthcare sector participants have come to realize that commercial success no longer depends solely on the product itself but also on achieving a consumer-compatible form of packaging and operation.

What You Will Learn

  • What are the marketed patient self-testing devices for measuring and monitoring anticoagulation drug therapy?
  • What is the status and prospects of coagulation self-test devices currently in development?
  • What is the market potential and commercialization risks and opportunities for coagulation self-test devices?
  • What are the key patient self-test device design issues and evolving market factors for coagulation self-testing?
  • What is the impact of coagulation self-test technology and devices on coagulation management markets?
  • What is the role and impact of third-party PT/INR self-test services on device demand and patient acceptance?
  • Who are the market participants in the coagulation self-test segment, and what are their technology and market strategies?
  • Who are the market leaders; what is the size of the market today, and what will it be in 2020?
  • What is the impact of novel oral anticoagulants on the future commercial growth of coagulation self-test devices?

Table of Contents

Summary of Contents

Executive Summary

Anticoagulation Therapy Market Dynamics

  • Anticoagulation Healthcare Economics
    • Oral Anticoagulation Therapy
    • Monitoring Prothrombin Time
    • Competing Coagulation Tests
    • Key Factors in Patient Compliance
    • Market Drivers
    • Industry Alignment and Competitive Landscape

Coagulation Self-Testing Device Design Factors

  • Standardization of PT/INR Testing
    • Accuracy and Precision
    • Sampling Method
    • Endpoint Detection
    • Patient/User Interface
    • Wireless Technology

Commercialization Factors

  • Managed Care and Reimbursement
    • Third-party Patient Training & Support
    • Proprietary Technology

Market Factors

  • Indications and Market Segments
    • Novel Oral Anticoagulants
    • Patient Demographics
    • Regulations and Standards
    • Patient/Consumer Sentiment

Patient Self-Testing Product Assessments

  • Commercial Products
    • CoaguChek
    • CoaguSense
    • InRatio
    • i-STAT
  • Development-Stage Devices
    • iLine Microsystems
    • Microvisk
    • Universal Biosensors
    • FlexLife Health

Market Analysis, Data and Forecasts

  • North America
    • Western Europe
    • Eastern Europe
    • Asia
    • MENA
    • South America

Company Profiles

Back to Top